Background Inflammatory bowel disease (IBD) is a lifelong condition with no cure. Patients
with IBD might experience symptoms of common mental disorders such as anxiety and …

OBJECTIVES: In 2015, the Selecting Therapeutic Targets in Inflammatory Bowel Disease
(STRIDE) program proposed shifting the therapeutic focus on ulcerative colitis (UC) toward …

There are several scoring systems presently available to classify disease severity in
ulcerative colitis [UC] within the multiple domains of disease activity, which aid objective …

Fatigue is an important clinical problem in patients with IBD, affecting nearly 50% of patients
in clinical remission and> 80% of those with active disease. The resulting decrease in …

Background and Aims Inflammatory bowel disease (IBD) is a chronic relapsing and remitting
disease with high morbidity, substantial health care costs, and increasing incidence. Fatigue …

This is the second European Crohn's and Colitis Organisation [ECCO] evidence-based
consensus on extraintestinal manifestations [EIMs] of inflammatory bowel disease [IBD] and …

1.1. Aim The overarching aim of ECCO is to improve the care of patients with IBD through
the development of guidelines, education and research. Current evidence is fundamental in …

Fatigue is a burdensome, multidimensional, and multifactorial symptom that is associated
with a wide array of chronic illnesses, specifically occurring in nearly 50% of patients with …

Background Fatigue is a debilitating and highly relevant symptom in patients with
inflammatory bowel disease (IBD). However, awareness of fatigue and treatment options …

Background Patients with inflammatory bowel disease report multiple symptoms, but the
relationships among co-occurring symptoms are poorly understood. This study aimed to …